Phase Ii, Open-Label Study of Brivanib As First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Clinical Cancer Research（2011）
Key words
Treatment,Cancer Progression
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined